诊断学理论与实践 ›› 2021, Vol. 20 ›› Issue (03): 251-256.doi: 10.16150/j.1671-2870.2021.03.005
王虹
收稿日期:2020-09-29
出版日期:2021-06-25
发布日期:2022-06-28
基金资助:
Received:2020-09-29
Online:2021-06-25
Published:2022-06-28
中图分类号:
王虹. 胃食管反流病的临床表现分类及精准治疗策略[J]. 诊断学理论与实践, 2021, 20(03): 251-256.
| [1] |
Vakil N, van Zanten SV, et al. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8):1900-1920.
doi: 10.1111/j.1572-0241.2006.00630.x URL |
| [2] |
Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification[J]. Gut, 1999, 45(2):172-180.
pmid: 10403727 |
| [3] |
El-Serag HB, Graham DY, Satia JA, et al. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis[J]. Am J Gastroenterol, 2005, 100(6):1243-1250.
pmid: 15929752 |
| [4] |
Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy[J]. Am J Gastroenterol, 2010, 105(5):1053-1061.
doi: 10.1038/ajg.2009.670 pmid: 19997095 |
| [5] |
Kasyap AK, Sah SK, Chaudhary S. Clinical spectrum and risk factors associated with asymptomatic erosive esophagitis as determined by Los Angeles classification: A cross-sectional study[J]. PLoS One, 2018, 13:e0192739.
doi: 10.1371/journal.pone.0192739 URL |
| [6] |
Ronkainen J, Talley NJ, Storskrubb T, et al. Erosive esophagitis is a risk factor for Barrett′s esophagus: a community-based endoscopic follow-up study[J]. Am J Gastroenterol, 2011, 106(11):1946-1952.
doi: 10.1038/ajg.2011.326 pmid: 21946284 |
| [7] |
Hsu PI, Lu CL, Wu DC, et al. Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis[J]. Clin Gastroenterol Hepatol, 2015, 13(5):859-866.
doi: 10.1016/j.cgh.2014.09.033 URL |
| [8] |
Takashima T, Iwakiri R, Sakata Y, et al. Endoscopic reflux esophagitis and Helicobacter pylori infection in young healthy Japanese volunteers[J]. Digestion, 2012, 86(1):55-58.
doi: 10.1159/000338849 pmid: 22722701 |
| [9] |
Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus[J]. Gut, 2018, 67(7):1351-1362.
doi: 10.1136/gutjnl-2017-314722 URL |
| [10] |
Aziz Q, Fass R, Gyawali CP, et al. Esophageal disorders[J]. Gastroenterology 2016, 150(6):1368-1379.
doi: 10.1053/j.gastro.2016.02.012 URL |
| [11] |
Patel DA, Higginbotham T, Slaughter JC, et al. Development and validation of a mucosal impedance contour analysis system to distinguish esophageal disorders[J]. Gastroenterology, 2019, 156(6):1617-1626.
doi: 10.1053/j.gastro.2019.01.253 URL |
| [12] |
Woodland P, Shen Ooi JL, Grassi F, et al. Superficial esophageal mucosal afferent nerves may contribute to reflux hypersensitivity in nonerosive reflux disease[J]. Gastroenterology, 2017, 153(5):1230-1239.
doi: S0016-5085(17)35923-1 pmid: 28734832 |
| [13] |
Chua YC, Aziz Q. Perception of gastro-oesophageal reflux[J]. Best Pract Res Clin Gastroenterol, 2010, 24(6):883-891.
doi: 10.1016/j.bpg.2010.10.003 pmid: 21126701 |
| [14] |
Willert RP, Delaney C, Kelly K, et al. Exploring the neurophysiological basis of chest wall allodynia induced by experimental oesophageal acidification - evidence of central sensitization[J]. Neurogastroenterol Motil, 2007, 19(4):270-278.
doi: 10.1111/j.1365-2982.2006.00890.x URL |
| [15] |
Coen SJ, Kano M, Farmer AD, et al. Neuroticism in fluences brain activity during the experience of visceral pain[J]. Gastroenterology, 2011, 141(3):909-917.
doi: 10.1053/j.gastro.2011.06.008 URL |
| [16] |
Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of gastroesophageal reflux disease: where Rome, Lyon, and Montreal Meet[J]. Clin Gastroenterol Hepatol, 2020, 18(4):767-776.
doi: 10.1016/j.cgh.2019.07.015 URL |
| [17] |
Kahrilas PJ, Howden CW, Wernersson B, et al. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study[J]. Aliment Pharmacol Ther, 2013, 37(10):1005-1010.
doi: 10.1111/apt.12298 URL |
| [18] |
Bell R, Lipham J, Louie B, et al. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial[J]. Gastrointest Endosc, 2019, 89(1):14-22.
doi: 10.1016/j.gie.2018.07.007 URL |
| [19] | Absah I, Rishi A, Talley NJ, et al. Rumination syndrome:pathophysiology, diagnosis, and treatment[J]. Neurogastroenterol Motil, 2017, 29(4):12954. |
| [20] |
Halland M, Parthasarathy G, Bharucha AE, et al. Dia-phragmatic breathing for rumination syndrome: efficacy and mechanisms of action[J]. Neurogastroenterol Motil, 2016, 28(3):384-391.
doi: 10.1111/nmo.12737 URL |
| [21] |
Pandolfino JE, Zhang QG, Ghosh SK, et al. Transientlower esophageal sphincter relaxations and reflux: mechanistic analysis using concurrent fluoroscopy and high-resolution manometry[J]. Gastroenterology, 2006, 131(6):1725-1733.
pmid: 17087957 |
| [22] |
Pauwels A, Broers C, Van Houtte B, et al. A Randomized double-blind, placebo-controlled, cross-over study using baclofen in the treatment of rumination syndrome[J]. Am J Gastroenterol, 2018, 113(1):97-104.
doi: 10.1038/ajg.2017.441 pmid: 29206813 |
| [23] |
Zerbib F, Roman S, Bruley Des Varannes S, et al. Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility[J]. Clin Gastroenterol Hepatol, 2013, 11(4):366-372.
doi: 10.1016/j.cgh.2012.10.041 URL |
| [24] | Woodland P, Singendonk MMJ, Ooi J, et al. Measurement of salivary pepsin to detect gastroesophageal reflux di-sease is not ready for clinical application[J]. Clin Gas-troenterol Hepatol, 2019, 17(3):563-565. |
| [25] |
Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole[J]. Laryngoscope, 2006, 116(2):254-260.
doi: 10.1097/01.mlg.0000192173.00498.ba URL |
| [26] |
Gyawali CP, Fass R. Management of gastroesophageal reflux disease[J]. Gastroenterology, 2018, 154(2):302-318.
doi: 10.1053/j.gastro.2017.07.049 URL |
| [27] |
Kahrilas PJ, Howden CW, Hughes N, et al. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease[J]. Chest, 2013, 143(3):605-612.
doi: S0012-3692(13)60137-3 pmid: 23117307 |
| [28] |
Toros SZ, Toros AB, Yüksel OD, et al. Association of laryngopharyngeal manifestations and gastroesophageal reflux[J]. Eur Arch Otorhinolaryngol, 2009, 266(3):403-409.
doi: 10.1007/s00405-008-0761-2 pmid: 18648836 |
| [29] |
Gomez Cifuentes J, Lopez R, et al. Factors predictive of gastroesophageal reflux disease and esophageal motility disorders in patients with non-cardiac chest pain[J]. Scand J Gastroenterol, 2018, 53(6):643-649.
doi: 10.1080/00365521.2018.1452975 URL |
| [30] |
Herregods TVK, Bredenoord AJ, Oors JM, et al. Determinants of the association between non-cardiac chest pain and reflux[J]. Am J Gastroenterol, 2017, 112(11):1671-1677.
doi: 10.1038/ajg.2017.288 pmid: 29016562 |
| [31] |
Sarkar S, Thompson DG, Woolf CJ, et al. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression[J]. Am J Gastroenterol, 2004, 99(10):1998-2006.
doi: 10.1111/j.1572-0241.2004.40174.x URL |
| [32] |
Kandulski A, Weigt J, Caro C, et al. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn[J]. Clin Gastroenterol Hepatol, 2015, 13(6):1075-1081.
doi: 10.1016/j.cgh.2014.11.033 URL |
| [1] | 唐陈月, 徐琛莹, 俞丽芬. 上海12 293例体检人群中酸相关性疾病的内镜检出特征分析[J]. 诊断学理论与实践, 2018, 17(01): 51-55. |
| [2] | 熊理守, 陈旻湖,. 非糜烂性反流病相关问题的研究现状[J]. 诊断学理论与实践, 2006, 5(01): 8-12. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
